
Desonide: A low-potency prescription steroid made for delicate skin. It is the usual step up from hydrocortisone for the face, the folds and young children. Protopic: A non-steroid ointment for eczema, used where steroids are hardest to keep using: the face, the eyelids, and skin folds. It carries a boxed warning that twenty years of follow-up have not supported.


Choose as the step up from hydrocortisone for delicate skin — face, eyelids, folds and babies.
Choose for eczema where steroids are hardest to keep using — face, eyelids, folds — or to prevent flares twice a week.
Can you take them together?
A common pairing for facial eczema: desonide for short flares, Protopic for steroid-free maintenance between them.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.













Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.

Inhibits calcineurin: Blocks a switch that helps activate T cells. Reduces immune messengers: T cells release fewer inflammation-driving signals. Calms eczema and itch: Redness and irritation ease as inflammation settles.
The drug binds FKBP-12 and inhibits calcineurin, reducing T-cell cytokine transcription; the complete atopic-dermatitis mechanism is not known. It also has other cellular effects.
When to Apply: Twice a day on the affected skin only, in a thin film. One fingertip unit, the amount along the last joint of an adult index finger, covers about two adult palms. Moisturizer goes on separately and continues after the course ends.
How to Start: Twice daily from day one until the rash is flat, not just calmer, usually one to two weeks. Two weeks is the usual limit on a face, up to four weeks on the body before review. In children, follow the prescriber's duration, not the size of the tube.
If It Irritates: Stinging is usually the base, not the drug, and likelier on broken skin or with an alcohol-containing gel or foam. The ointment settles it. Redness or itch that worsens over a week or two can be allergy to the steroid or a preservative, and needs a different product.
If It Is Not Working: Two weeks of proper twice-daily use is a fair test. If nothing changed, question the diagnosis, look for infection, and ask whether the site can take a stronger steroid. On thin skin the better next step is often a non-steroid such as tacrolimus.
When to Apply: A thin layer twice a day to the affected skin, rubbed in gently. It goes on the rash, not over clear skin. Keep moisturizer a couple of hours apart — layering one straight onto the other has not been studied.
How to Start: Twice a day until the patch clears, usually one to three weeks, then stop. Many people then move to maintenance — twice a week on the places that always flare, even when they look normal. That is well supported and makes flares less frequent.
If It Irritates: Burning or stinging for fifteen to thirty minutes after applying is very common in the first days and is not an allergy. It settles within about a week. Keeping the tube in the fridge, applying to dry rather than damp skin, and skipping alcohol early on all help.
If It's Not Working: Check it is going on twice a day — two to three weeks is a fair trial. Then the options are the higher strength if you are an adult on 0.03%, a short steroid course to break the flare, or a look at whether infection or a contact allergy is driving the rash.
No blood tests for a standard course in a healthy person. Monitoring is looking at the skin: did the rash clear, has the skin become thin or shiny, have small vessels or stretch marks appeared in the folds.
Children are watched more closely, not because desonide is dangerous but because they absorb proportionally more for their size. Prescribers watch how much is used per month, and whether a repeat pattern has quietly become daily use.
Low potency does not mean indefinite. Where a condition keeps flaring, the plan is short courses on flares with emollients doing the daily work, or a switch to a non-steroid such as tacrolimus or pimecrolimus for the face and folds. Around the eyes, prolonged steroid use of any potency raises the risk of glaucoma and cataract.
No blood tests are needed. Blood levels are usually undetectable with the ointment and fall further as the barrier repairs — the opposite of the oral form used after transplants. Monitoring is a check at two to three weeks on whether the rash responded, then a plan for maintenance.
The boxed warning is the part to understand. It says long-term safety is not established, that rare cases of lymphoma and skin cancer were reported in people who used these drugs, and that continuous long-term use should be avoided. It was added in 2006, based mainly on animal studies using very high doses by mouth or injection, plus scattered case reports.
What has happened since matters. Large cohort studies, and a registry that followed treated children for a decade, have not found the rise in lymphoma the warning describes. Guidelines in the United States and Europe still recommend these drugs, including on the face and eyelids and as twice-weekly maintenance. The concern was theoretical, more than twenty years of use has not borne it out, and how long to continue is still a decision to make with a doctor.
Day-to-day monitoring is simple: keep skin checks routine, use sun protection on treated areas, and pause during a skin infection.
Approximate windows, not promises.
First few minutesApplying it: A thin layer on the affected skin. Low potency, which suits the face, the eyelids and small children.
First few minutesApplying it: A thin layer twice a day. Burning or stinging for a short while afterward is common and worst in the first week.
Days 1 to 3Itch first: Itching and stinging settle before the rash looks different, which is often what lets a child sleep.
Days 3 to 10Clearing: Redness fades and rough or weeping skin settles. Most facial flares are largely better here.
Weeks 1 to 2Judge it here: On the face, stop and reassess here. Facial and eyelid eczema settle without the thinning risk a stronger steroid carries, and seborrheic dermatitis improves in the same window.
Weeks 2 to 4Folds and the body: Intertrigo and fold rashes respond, and the mildness suits a site that absorbs heavily; any yeast needs treating too. On the body, about four weeks before review.
After stoppingMarks stay behind: Brown or gray patches where the rash was are pigment change, not scarring, and fade over weeks to months.
Days 1 to 7Adjusting: Burning is at its worst now. Itch often improves in the same week, which is what gets most people through.
Weeks 1 to 3Working: Redness and thickening settle and the burning has usually stopped. Most people reach their best result here.
MaintenanceKeeping flares apart: Once clear, twice-weekly use on the trouble spots lengthens the gaps between flares. Licensed, not an improvisation.
Sorted by what to do about them.
Generic desonide cream, ointment and lotion are cheap and well covered. The branded gel and foam, easier to use on faces and hairy areas, cost considerably more, and plans often ask for a generic first.
It costs more than over-the-counter hydrocortisone, which needs no visit, and less than non-steroids like tacrolimus or crisaborole. If cost is a barrier, start with the cream or ointment.
Both strengths come as generics, which brought the price down a long way, though it still costs more than a generic steroid ointment. Prices vary widely between pharmacies and discount cards sometimes beat insurance, so check more than one.
Prior authorization is still common, usually asking that a topical steroid was tried first. Tube size is the practical variable: twice-daily use means a small tube treating a child's face lasts far longer than the same tube on two hands.
Yes, by a step or two, and both are low potency. Well below mid-potency steroids like triamcinolone.
That is largely what it is for. Keep courses to about two weeks and stop once the rash is flat. Repeated face use is a reason to ask about a non-steroid.
A common choice in children, and some formulations are approved from a few months of age. Follow the prescriber's duration, and remember a diaper acts as a dressing.
A short course at this potency is unlikely to. Thinning comes from stronger steroids, thin sites and long use. Untreated eczema has its own costs: months of scratching and more pigment change.
It can, less readily than stronger steroids. Pale patches show more on deeper skin tones and recover slowly. Untreated inflammation also leaves light and dark marks.
Several steps of potency. Triamcinolone on a face or in a fold for two weeks can cause thinning and stretch marks desonide would not. Matching steroid to site is why both exist.
Yes, and it is printed on the label — long-term safety is not established, and rare cases were reported. Studies following large groups for years have not found the increased risk. A caution, not a demonstrated harm.
It acts on nerve endings in inflamed skin as well as on immune cells. Burning is worst in the first few days and gone within a week as the rash heals.
Yes — eyelid eczema is one of the main reasons it gets prescribed. Keep it off the eye itself and the lid margin.
Alcohol flushing is a known effect while using it. Harmless, and it stops when the treatment does.
The label asks for the shortest suitable use and for breaks. Twice-weekly maintenance on trouble spots is licensed and widely used. Make that decision with a doctor rather than leaving a prescription running.
No. Blood levels are usually undetectable with the ointment. The tablets are a different treatment entirely.